PGS Using Microarray in IVF Patients With Repeated Implantation Failure
Preimplantation Genetic Screening (PGS) Using Microarray Technique: Method to Select the Embryo With the Greatest Chance for Successful Implantation During in Vitro Fertilization in Couples With a History of Unsuccessful IVF Attempts
1 other identifier
interventional
130
1 country
1
Brief Summary
This project intends to use preimplantation genetic screening (PGS) with the microarray technique to determine the chromosome composition of fertilized eggs, so that only chromosomally normal embryos are transferred during IVF. The purpose is to increase the probability of pregnancy and childbirth among couples with a history of repeated unsuccessful IVF attempts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 10, 2014
CompletedFirst Posted
Study publicly available on registry
October 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedOctober 20, 2014
October 1, 2014
1.8 years
October 10, 2014
October 17, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ongoing pregnancy per randomized patient
2 years
Secondary Outcomes (2)
cumulative pregnancy rate,
3 years
miscarriage rate during the first 18 weeks of pregnancy
2 years
Study Arms (2)
PGS
EXPERIMENTALblastocyst biopsy and chromosomal analysis
control
NO INTERVENTIONregular IVF
Interventions
Eligibility Criteria
You may qualify if:
- Couples who meet the criteria for IVF treatment and who have a history of at least three previous IVF cycles including embryo transfer without delivery.
- The woman may be a maximum of 39 years old when the study is carried out and must have a normal-good ovarian reserve (at least 12 antral follicles).
- Her partner must be able to provide a semen sample containing live sperm.
- Women included in the study will not participate in any other research project.
You may not qualify if:
- Myoma, or other uterine lesions judged to affect implantation.
- Nonspecific cysts that are not considered to be functional.
- Endometrium \>3 cm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fertilitetscentrum AB
Gothenburg, 40229, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2014
First Posted
October 16, 2014
Study Start
August 1, 2014
Primary Completion
June 1, 2016
Last Updated
October 20, 2014
Record last verified: 2014-10